Women with a higher risk of developing breast cancer are set to be offered a pill that cuts their risk of developing the disease in half. NHS England and UK medication watchdogs announced the pill ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Postmenopausal women with ductal carcinoma in situ experienced comparable rates of recurrence but ...

Please provide your email address to receive an email when new articles are posted on . Adding the ER antagonist fulvestrant to anastrozole provided no benefit to women with hormone-receptor-positive ...

Faslodex (fulvestrant) improved overall survival by nearly six months compared with anastrozole as initial hormone therapy for postmenopausal women with estrogen receptor-positive advanced breast ...

Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: ...

August 7, 2006 — Anastrazole should now be the preferred initial adjuvant treatment for postmenopausal women with hormone-sensitive early-stage breast cancer, instead of the current standard, ...

High-Dose Versus Standard Chemotherapy in Metastatic Breast Cancer: Comparison of Cancer and Leukemia Group B Trials With Data From the Autologous Blood and Marrow Transplant Registry PURPOSE: To ...

Enclomiphene is a non-steroidal selective estrogen receptor modulator (SERM) sometimes used to treat male secondary hypogonadism, or low testosterone caused by problems with the hypothalamus or ...

September 8, 2008 — The foveas of women using anastrozole to prevent breast cancer recurrence appear to be subjected to more tractional force than the foveas of women not using any hormonal medication ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Carpal tunnel ...

Compared with anastrozole alone, the combination of fulvestrant and anastrozole significantly improved time without disease progression and extended the median overall survival of women with endocrine ...

Waldenström's macroglobulinemia is a lymphoproliferative disorder characterized by a lymphoplasmacytic bone marrow infiltrate and high levels of a monoclonal IgM in serum. 1 A number of ...